IRC
DPLO

Investors Research Corp’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Investors Research Corp’s Portfolio DPLO Stock Details DPLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-87,977
Closed -$352K – 1179
2019
Q4 		$352K Sell
87,977
-350
-0.4% -$1.64K 0.16% 188
2019
Q3 		$433K Sell
88,327
-1,400
-2% -$7.83K 0.22% 153
2019
Q2 		$546K Sell
89,727
-1,600
-2% -$8.5K 0.29% 123
2019
Q1 		$531K Sell
91,327
-700
-0.8% -$7.23K 0.28% 122
2018
Q4 		$1.24M Hold
92,027
– – 0.87% 12
2018
Q3 		$1.79M Sell
92,027
-3,123
-3% -$66.5K 1.02% 6
2018
Q2 		$2.43M Buy
95,150
+1,200
+1% +$28K 1.41% 1
2018
Q1 		$1.89M Sell
93,950
-2,600
-3% -$60.7K 1.15% 2
2017
Q4 		$1.94M Buy
+96,550
New +$1.9M 1.2% 1

Other funds holding DPLO

GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Investors Research Corp's DPLO Position: Q1 2020 in Review

Investors Research Corp sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q1 2020, closing a stake of 87,977 shares — an estimated $352K sold.

Investors Research Corp first reported a position in DPLO in Q4 2017 and held it in 9 quarters. The position peaked at $2.43M in Q2 2018. 1 fund tracked by Wall St. Rank holds DPLO as of Q1 2020.

  • Investors Research Corp reported no remaining DIPLOMAT PHARMACY, INC. position as of Q1 2020 after selling out during the quarter.
  • Investors Research Corp sold 87,977 DIPLOMAT PHARMACY, INC. shares in Q1 2020, an estimated $352K.
  • Investors Research Corp first reported a position in DIPLOMAT PHARMACY, INC. in Q4 2017 and held it in 9 quarters.
  • Investors Research Corp's DIPLOMAT PHARMACY, INC. position peaked at $2.43M in Q2 2018.
  • 1 fund tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q1 2020.

Based on Investors Research Corp's 13F filing for Q1 2020, filed 5 May 2020.